Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

Zika Virus: Immunity and Vaccine Development

(2016) Theodore C. Pierson et al.   CELL

A Mouse Model of Zika Virus Pathogenesis

(2016) Helen M. Lazear et al.   Cell Host & Microbe

Vaccine protection against Zika virus from Brazil

(2016) Rafael A. Larocca et al.   NATURE

Rapid development of a DNA vaccine for Zika virus

(2016) K. A. Dowd et al.   SCIENCE

Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys

(2016) P. Abbink et al.   SCIENCE

A rhesus macaque model of Asian-lineage Zika virus infection

(2016) Dawn M. Dudley et al.   Nature Communications

Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype

(2016) Kimberly A. Dowd et al.   Cell Reports

Preventative Vaccines for Zika Virus Outbreak: Preliminary Evaluation

(2016) Eun Kim et al.   EBioMedicine

In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine

(2016) Karuppiah Muthumani et al.   npj Vaccines

Current status and future prospects of yellow fever vaccines

(2015) Andrew S Beck et al.   Expert Review of Vaccines

N 1 -methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice

(2015) Oliwia Andries et al.   JOURNAL OF CONTROLLED RELEASE

Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes

(2015) Norbert Pardi et al.   JOURNAL OF CONTROLLED RELEASE

Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals

(2015) Andreas Thess et al.   MOLECULAR THERAPY

Dengue vaccine: hypotheses to understand CYD-TDV-induced protection

(2015) Bruno Guy et al.   NATURE REVIEWS MICROBIOLOGY

Live attenuated vaccines: Historical successes and current challenges

(2015) Philip D. Minor   VIROLOGY

mRNA transcript therapy

(2014) Drew Weissman   Expert Review of Vaccines

Variation of the Specificity of the Human Antibody Responses after Tick-Borne Encephalitis Virus Infection and Vaccination

(2014) J. Jarmer et al.   JOURNAL OF VIROLOGY

Construction and Evaluation of Novel Rhesus Monkey Adenovirus Vaccine Vectors

(2014) Peter Abbink et al.   JOURNAL OF VIROLOGY

mRNA-based therapeutics — developing a new class of drugs

(2014) Ugur Sahin et al.   NATURE REVIEWS DRUG DISCOVERY

Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics

(2013) Martin A Maier et al.   MOLECULAR THERAPY

Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo

(2012) Muthusamy Jayaraman et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults

(2010) J.E. Ledgerwood et al.   VACCINE

Efficient Assembly and Secretion of Recombinant Subviral Particles of the Four Dengue Serotypes Using Native prM and E Proteins

(2009) Pei-Gang Wang et al.   PLoS One

Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability

(2008) Katalin Karikó et al.   MOLECULAR THERAPY